Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinomaDaniel Shu(University of Maryland, Baltimore), Mark Yarchoan(Johns Hopkins University)Nature ImmunologyOctober 25, 202410.1038/s41590-024-01992-wCited by 84SaveCiteExport RISWatch citationsRelated PapersTumor-derived CCL2 drives tumor growth and immunosuppression in IDH1-mutant cholangiocarcinoma|Hepatology|2024|9